Opinion

Video

Gaps Between Guidelines and Clinical Practice Patterns in ASCVD

Experts on the management of ASCVD discuss clinical practice patterns of high-risk patients and the common reasons for clinicians not intensifying cholesterol treatment.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
1 KOL is featured in this series.
1 expert in this video
1 expert in this video
Related Content
Cardiomyopathy (ATTR-CM) -- Image credit: Dzmitry | stock.adobe.com
July 1st 2025

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Gillian McGovern, Associate Editor Jennifer Goldman, PharmD, CDES, BC-ADM, FCCP
An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial
July 1st 2025

An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Timing of Antihypertensive Medication Yields No Benefit in Older Adults With Frailty
June 24th 2025

Timing of Antihypertensive Medication Yields No Benefit in Older Adults With Frailty

Danielle Valletti, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Heart-healthy foods -- Image credit: marilyn barbone | stock.adobe.com
June 11th 2025

The Role of Pharmacists in Cardiovascular Health: A Collaborative Approach to Treatment, Counseling, and Nutrition

Megan Smith, PharmD
Doctor measuring patient's blood pressure | Image Credit: © grinny - stock.adobe.com
June 9th 2025

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Alexandra Gerlach, Associate Editor